Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedUpdates to version to v3.2.0 and addition of a government-operating-status notice; removal of a specific disease name (B-cell chronic lymphocytic leukemia) from the content. The new notice may affect user expectations about data freshness and response times.SummaryDifference4%
- Check18 days agoChange DetectedPage updated to version v3.1.0 and adds information about B-cell lymphoma; previous version tag v3.0.2 is removed.SummaryDifference0.2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage updated to v3.0.2 from v3.0.1; 'Back to Top' link removed.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has been updated to include new drug information and resources related to B-cell chronic lymphocytic leukemia, while removing some previous drug information and resources. The facility name and location details have also been added.SummaryDifference12%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference1%
Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.